Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma

BACKGROUND: The current standard of care for classical Hodgkin lymphoma (HL) is multiagent chemotherapy with or without radiation. In patients who relapse or fail to respond, additional high-dose chemotherapy with autologous hematopoietic stem cell transplantation (AHSCT) can improve progression-fre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Hematol Oncol
Autors principals: Johnston, Patrick B., Pinter-Brown, Lauren C., Warsi, Ghulam, White, Kristen, Ramchandren, Radhakrishnan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5948762/
https://ncbi.nlm.nih.gov/pubmed/29774169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-018-0103-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars